| Issue |
Section |
Title |
File |
| No 4 (2016) |
Articles |
Medically induced abortion at 12 to 22 weeks gestation: Indications, methods, and results |
|
| No 7 (2017) |
Articles |
Lotus I: A Phase III randomized controlled trial of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization, with focus on the Russian subpopulation |
|
| No 12 (2018) |
Articles |
Multicomponent therapy in patients with pelvic inflammatory diseases |
|
| No 1 (2020) |
Articles |
Premature birth: past restrictions and new opportunities |
|
| No 12 (2019) |
Articles |
Noninvasive prenatal testing in Russia: a population study |
|
| No 12 (2019) |
Articles |
Metabolomic profile in pregnant women with fetal growth restriction |
|
| No 6 (2020) |
Articles |
Iron deficiency states during pregnancy: prevention and treatment |
|
| No 7 (2020) |
Articles |
The use of a new topical combination drug (metronidazole + chloramphenicol + natamycin + hydrocortisone acetate) for the treatment of vaginitides of various etiologies |
|
| No 3 (2020) |
Articles |
Use of placental therapy in the correction of functional impairments in women: investigations and clinical practice |
|
| No 1 (2021) |
Articles |
INITIAL RESULTS OF CLINICAL APPLICATION OF MESENCHYMAL STROMAL STEM CELL-DERIVED EXTRACELLULAR MICROVESICLES AFTER ABDOMINAL DELIVERY |
|
| No 6 (2021) |
Articles |
Risk factors for infectious and inflammatory diseases of the lower genital tract in women using contraception |
|
| No 9 (2021) |
Articles |
Current understanding of the relationship between gut and vaginal microbiotas |
|
| No 4 (2022) |
Articles |
Feasibility of delivery in patients receiving mesenchymal stromal cell-derived extracellular microvesicles during the previous caesarean section |
|
| No 8 (2023) |
Clinical Notes |
Resolution of the Council of Experts in obstetrics-gynecology, dermatovenerology, gastroenterology and microbiology "Principles of intimate hygiene in healthy women and in vulvar diseases" |
|
| No 9 (2023) |
Original Articles |
Delivery of patients with a uterine scar who have undergone cell technology in a previous caesarean section |
|
| No 12 (2023) |
Original Articles |
Paradigm shift in pharmacotherapy for late-onset preeclampsia: advantages of two-component antihypertensive therapy compared to monotherapy based on analysis of vasoactive status data in pregnant women |
|
| No 11 (2023) |
Reviews |
Systematic review of the efficacy and safety of nifuratel for women with diseases accompanied by pathological discharge from the genital tract |
|
| No 11 (2023) |
Original Articles |
Pathogenetic rationale for the ineffectiveness of antihypertensive therapy based on vasoactive status analysis in patients with early-onset preeclampsia |
(Rus)
|
| No 6 (2024) |
Reviews |
Role of maternal hemodynamics in choosing antihypertensive therapy: concept shift |
|
| No 7 (2024) |
Exchange of Experience |
Analysis of perinatal and infant outcomes in children born to mothers who were administered cellular technologies during cesarean section |
|
| No 8 (2024) |
Articles |
The safety of hormone therapy during pregnancy. Joint statement by experts in reproductive medicine, obstetrics and gynecology, endocrinology, clinical pharmacology, neonatology and pediatrics |
|
| No 2 (2025) |
Guidelines for the Practitioner |
Reproductive potential in married couple: the role of micronutrients in the preconception period |
|
| No 3 (2025) |
Original Articles |
Predictors of pregnancy rate in assisted reproductive technologies: results of the iris observational program in the population of Russia and Kazakhstan |
|
| No 5 (2025) |
Original Articles |
Changes in placental growth factor levels in patients with different pregnancy complications |
|
| No 6 (2025) |
Reviews |
Polymicrobial infections and bacterial vaginosis: past, present and future |
|
